The impact of the 2020 COVID-19-related suspension of BreastScreen NSW on breast cancer tumour size and treatment.

IF 2.5 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Public Health Research & Practice Pub Date : 2023-09-13 DOI:10.17061/phrp32342217

Amanda A Jayakody, Kan Ren, Richard J Walton, Matthew E Warner-Smith, Nicola Scott, Anthea M Temple, Chirag Mistry, Sarah J McGill

{"title":"The impact of the 2020 COVID-19-related suspension of BreastScreen NSW on breast cancer tumour size and treatment.","authors":"Amanda A Jayakody, Kan Ren, Richard J Walton, Matthew E Warner-Smith, Nicola Scott, Anthea M Temple, Chirag Mistry, Sarah J McGill","doi":"10.17061/phrp32342217","DOIUrl":null,"url":null,"abstract":"The coronavirus disease 2019 (COVID-19) pandemic resulted in the temporary closure of many population-based cancer screening programs worldwide1, including BreastScreen NSW, which was temporarily paused for 7 weeks in 2020 in response to safety considerations. From June 2021, BreastScreen NSW again suspended services in the state of New South Wales (NSW) due to the increasing incidence of the COVID-19 Delta strain and the need to redeploy staff to support the pandemic response. While services have reopened, there is concern among clinicians and public health professionals internationally about the potential adverse impacts of service suspensions on breast cancer morbidity and mortality, and a call for shared learnings on best practice for the resumption of services.1 This retrospective observational study aimed to examine data before and after the 2020 BreastScreen NSW suspension to assess the impact on tumour size in breast cancer diagnoses, and volumes of mastectomy and breast-conserving surgery.","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":"33 3","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health Research & Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17061/phrp32342217","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 2

Abstract

The coronavirus disease 2019 (COVID-19) pandemic resulted in the temporary closure of many population-based cancer screening programs worldwide1, including BreastScreen NSW, which was temporarily paused for 7 weeks in 2020 in response to safety considerations. From June 2021, BreastScreen NSW again suspended services in the state of New South Wales (NSW) due to the increasing incidence of the COVID-19 Delta strain and the need to redeploy staff to support the pandemic response. While services have reopened, there is concern among clinicians and public health professionals internationally about the potential adverse impacts of service suspensions on breast cancer morbidity and mortality, and a call for shared learnings on best practice for the resumption of services.1 This retrospective observational study aimed to examine data before and after the 2020 BreastScreen NSW suspension to assess the impact on tumour size in breast cancer diagnoses, and volumes of mastectomy and breast-conserving surgery.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

2020年新冠肺炎相关暂停新南威尔士州乳房筛查对乳腺癌肿瘤大小和治疗的影响

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Public Health Research & Practice PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

6.70

自引率

0.00%

发文量

审稿时长

20 weeks

期刊介绍： Public Health Research & Practice is an open-access, quarterly, online journal with a strong focus on the connection between research, policy and practice. It publishes innovative, high-quality papers that inform public health policy and practice, paying particular attention to innovations, data and perspectives from policy and practice. The journal is published by the Sax Institute, a national leader in promoting the use of research evidence in health policy. Formerly known as The NSW Public Health Bulletin, the journal has a long history. It was published by the NSW Ministry of Health for nearly a quarter of a century. Responsibility for its publication transferred to the Sax Institute in 2014, and the journal receives guidance from an expert editorial board.